Departments of Clinical Pharmacology & Pharmacology in association with the Division of Research, JIPMER Puducherry is organizing "National Workshop On Good Clinical Practice (GCP)". The last date for registration is 23-02-2022.
Topics to be covered
-
Good clinical Practice - an overview.
-
The New drug and clinical trials (NDCT) rules , 2019.
-
Roles and responsibilities of ethics committee in the clinical trials.
-
Roles and responsibilities of investigators and study team in the clinical trials.
-
Informed consent process.
-
Roles and responsibilities of Sponsor in clinical trials.
-
Record keeping and archival of Essential documents.
-
Audits, inspection and monitoring in clinical trials - site preparedness.
-
GCP compliance in investigator initiator trials.
-
Group exercises.
List of speakers
-
Dr. Samir Malhotra, Professor & Head, Dept. of Pharmacology, PGIMER, Chandigarh.
-
Dr.Nithya Gogtay, Professor &. Head, Dept. of Clinical Pharmacology, KEM, Mumbai.
-
Dr. Usha Rani Pingali, Professor & Head, Dept of Clinical Pharmacology, NIMS, Hyderabad.
-
Dr. Sanish Davis, R&D Director, Janssen (J&J) Pharmaceuticals, India.
-
Dr. Jayanthi M, Addl. Professor & Head, Dept of Pharmacology, JIPMER.
-
Dr. Melvin George, Associate Professor, Dept of Clinical Pharmacology, SRM MC & RC, Chennai.
-
Dr. Prasanth Ganesan, Additional Professor & Head, Dept of Medical Oncology, JIPMER.
-
Dr.Vyankatesh Shivane, Consultant Diabetologist, KEM Hospital, Mumbai.
-
Dr. S. Sandhiya, Addl. Professor & Head, Dept of Clinical Pharmacology, JIPMER.
-
Drs Akila S, Santhosh S, Ilanthamizhan J.
Target audience
-
Researchers from academia and industry,Faculty and Postgraduates, Research Scholars, Members of ethics and scientific committees.
Registration details
Registration fee: Rs. 500
Link for online registration: Click here.
Last date for registration: 23-02-2022
For online payment:
Contact information
-
Dr. Santhosh S (8762866584); Dr Ilanthamizhan J (8098043872)
-
E-mail: [email protected]
-
Note: Registration acknowledgement and other correspondences will be by e-mail only
For more information, click here.
